Cutaneous Drug Reaction Due to Bortezomib Characterized by Erythematous Reticular Plaques in a Patient With Multiple Myeloma. Dermatol Pract Concept 2024, 14 (4), e2024243. https://doi.org/10.5826/dpc.1404a243.